Hikma ends purchase talks with GSK related to assets in Egypt, Tunisia Read More
TOP NEWS: GSK, partner Vir chase US emergency use for virus antibody Read More
J&J, ViiV Healthcare drug combo provides long-term HIV suppression Read More
EXECUTIVE CHANGES: On The Beach adds Justine Greening to board Read More
BROKER RATINGS: Prudential, Pennon and Royal Mail get upgrades Read More
European Regulator Recommends GlaxoSmithKline's Dostarlimab Approval Read More
GlaxoSmithKline To Amend Covid-19 Treatment Study To Confirm Findings Read More
IN BRIEF: GlaxoSmithKline HR Chief Buys USD117,000 In Shares Read More
UPDATE: Sanofi Supports GSK And Johnson & Johnson With Covid Vaccines Read More
TOP NEWS: Sanofi, GSK Begin Covid Vaccine Candidate Phase Two Study Read More
LONDON MARKET MIDDAY: UK Banks Fall After Barclays Posts Profit Drop Read More
LONDON MARKET OPEN: Smith & Nephew Sinks After Covid-19 Hits Earnings Read More
GlaxoSmithKline Sets New Gender And Diversity Targets For 2025 Read More
TOP NEWS: GSK, Vir Expand Deal To Include New Influenza Therapies Read More
GSK Starts Respiratory Syncytial Virus Candidate Vaccine Programme Read More
Moody's Affirms GSK's A2 Senior Unsecured Ratings; Outlook Negative Read More
BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy Read More
UK Dividends Calendar - Next 7 Days Read More
Novartis's Sandoz To Bolster Antibiotics With GSK Cephalosporin Buy Read More
BROKER RATINGS: Investec Cuts NatWest To Sell; UBS Raises Aggreko Read More
